UNIVERSAL TECHNICAL INSTITUT (UTI) Fundamental Analysis & Valuation

NYSE:UTI • US9139151040

Current stock price

37.19 USD
-0.77 (-2.03%)
At close:
37.19 USD
0 (0%)
After Hours:

This UTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UTI Profitability Analysis

1.1 Basic Checks

  • In the past year UTI was profitable.
  • UTI had a positive operating cash flow in the past year.
  • In the past 5 years UTI has always been profitable.
  • UTI had a positive operating cash flow in each of the past 5 years.
UTI Yearly Net Income VS EBIT VS OCF VS FCFUTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M

1.2 Ratios

  • UTI has a better Return On Assets (6.44%) than 73.97% of its industry peers.
  • UTI's Return On Equity of 15.98% is fine compared to the rest of the industry. UTI outperforms 75.34% of its industry peers.
  • UTI has a Return On Invested Capital of 8.69%. This is in the better half of the industry: UTI outperforms 76.71% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 10.75%.
  • The 3 year average ROIC (7.27%) for UTI is below the current ROIC(8.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.44%
ROE 15.98%
ROIC 8.69%
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
UTI Yearly ROA, ROE, ROICUTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • UTI has a Profit Margin of 6.28%. This is in the better half of the industry: UTI outperforms 65.75% of its industry peers.
  • In the last couple of years the Profit Margin of UTI has grown nicely.
  • Looking at the Operating Margin, with a value of 8.38%, UTI is in the better half of the industry, outperforming 67.12% of the companies in the same industry.
  • In the last couple of years the Operating Margin of UTI has grown nicely.
  • UTI has a Gross Margin (49.62%) which is comparable to the rest of the industry.
  • UTI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.38%
PM (TTM) 6.28%
GM 49.62%
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
UTI Yearly Profit, Operating, Gross MarginsUTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. UTI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UTI is destroying value.
  • The number of shares outstanding for UTI has been increased compared to 1 year ago.
  • Compared to 5 years ago, UTI has more shares outstanding
  • Compared to 1 year ago, UTI has an improved debt to assets ratio.
UTI Yearly Shares OutstandingUTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
UTI Yearly Total Debt VS Total AssetsUTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • UTI has an Altman-Z score of 4.06. This indicates that UTI is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.06, UTI is doing good in the industry, outperforming 79.45% of the companies in the same industry.
  • The Debt to FCF ratio of UTI is 6.28, which is on the high side as it means it would take UTI, 6.28 years of fcf income to pay off all of its debts.
  • UTI has a Debt to FCF ratio of 6.28. This is in the better half of the industry: UTI outperforms 71.23% of its industry peers.
  • UTI has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • UTI has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 6.28
Altman-Z 4.06
ROIC/WACC0.97
WACC8.93%
UTI Yearly LT Debt VS Equity VS FCFUTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • UTI has a Current Ratio of 1.14. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of UTI (1.14) is comparable to the rest of the industry.
  • UTI has a Quick Ratio of 1.14. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
  • UTI has a Quick ratio of 1.14. This is comparable to the rest of the industry: UTI outperforms 49.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
UTI Yearly Current Assets VS Current LiabilitesUTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. UTI Growth Analysis

3.1 Past

  • UTI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • The Earnings Per Share has been growing by 65.96% on average over the past years. This is a very strong growth
  • UTI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.59%.
  • Measured over the past years, UTI shows a very strong growth in Revenue. The Revenue has been growing by 22.67% on average per year.
EPS 1Y (TTM)0%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%-42.5%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%9.64%

3.2 Future

  • Based on estimates for the next years, UTI will show a small growth in Earnings Per Share. The EPS will grow by 5.89% on average per year.
  • UTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.84% yearly.
EPS Next Y-31.19%
EPS Next 2Y-10.25%
EPS Next 3Y5.89%
EPS Next 5YN/A
Revenue Next Year9.48%
Revenue Next 2Y8.9%
Revenue Next 3Y8.84%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UTI Yearly Revenue VS EstimatesUTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
UTI Yearly EPS VS EstimatesUTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. UTI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 38.34 indicates a quite expensive valuation of UTI.
  • UTI's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, UTI is valued quite expensively.
  • A Price/Forward Earnings ratio of 40.50 indicates a quite expensive valuation of UTI.
  • UTI's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, UTI is valued quite expensively.
Industry RankSector Rank
PE 38.34
Fwd PE 40.5
UTI Price Earnings VS Forward Price EarningsUTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • UTI's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 60.27% of the companies in the same industry are more expensive than UTI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 126.79
EV/EBITDA 18.55
UTI Per share dataUTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • UTI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.58
EPS Next 2Y-10.25%
EPS Next 3Y5.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UTI Dividend Analysis

5.1 Amount

  • No dividends for UTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UTI Fundamentals: All Metrics, Ratios and Statistics

UNIVERSAL TECHNICAL INSTITUT

NYSE:UTI (3/27/2026, 8:04:00 PM)

After market: 37.19 0 (0%)

37.19

-0.77 (-2.03%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners97.17%
Inst Owner Change7.31%
Ins Owners2.7%
Ins Owner Change3.59%
Market Cap2.05B
Revenue(TTM)855.03M
Net Income(TTM)53.69M
Analysts81.82
Price Target38.42 (3.31%)
Short Float %6.37%
Short Ratio4.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.57%
Min EPS beat(2)28.91%
Max EPS beat(2)66.22%
EPS beat(4)4
Avg EPS beat(4)59.42%
Min EPS beat(4)28.91%
Max EPS beat(4)73.27%
EPS beat(8)7
Avg EPS beat(8)48.68%
EPS beat(12)11
Avg EPS beat(12)85.96%
EPS beat(16)14
Avg EPS beat(16)183.11%
Revenue beat(2)2
Avg Revenue beat(2)0.64%
Min Revenue beat(2)0.47%
Max Revenue beat(2)0.82%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.01%
Revenue beat(12)12
Avg Revenue beat(12)2.35%
Revenue beat(16)15
Avg Revenue beat(16)2.9%
PT rev (1m)0.64%
PT rev (3m)0.64%
EPS NQ rev (1m)-109.53%
EPS NQ rev (3m)-103.82%
EPS NY rev (1m)0.72%
EPS NY rev (3m)-1.83%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 38.34
Fwd PE 40.5
P/S 2.39
P/FCF 126.79
P/OCF 26.42
P/B 6.09
P/tB 7.14
EV/EBITDA 18.55
EPS(TTM)0.97
EY2.61%
EPS(NY)0.92
Fwd EY2.47%
FCF(TTM)0.29
FCFY0.79%
OCF(TTM)1.41
OCFY3.79%
SpS15.54
BVpS6.11
TBVpS5.21
PEG (NY)N/A
PEG (5Y)0.58
Graham Number11.54
Profitability
Industry RankSector Rank
ROA 6.44%
ROE 15.98%
ROCE 11.63%
ROIC 8.69%
ROICexc 11.82%
ROICexgc 13.27%
OM 8.38%
PM (TTM) 6.28%
GM 49.62%
FCFM 1.89%
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score7
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 6.28
Debt/EBITDA 0.93
Cap/Depr 181.06%
Cap/Sales 7.17%
Interest Coverage 13.88
Cash Conversion 73.39%
Profit Quality 30.06%
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 4.06
F-Score7
WACC8.93%
ROIC/WACC0.97
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%-42.5%
EPS Next Y-31.19%
EPS Next 2Y-10.25%
EPS Next 3Y5.89%
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%9.64%
Revenue Next Year9.48%
Revenue Next 2Y8.9%
Revenue Next 3Y8.84%
Revenue Next 5YN/A
EBIT growth 1Y-0.64%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year46.18%
EBIT Next 3Y27.41%
EBIT Next 5YN/A
FCF growth 1Y371.76%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y35.47%
OCF growth 3Y28.35%
OCF growth 5Y54.57%

UNIVERSAL TECHNICAL INSTITUT / UTI Fundamental Analysis FAQ

What is the fundamental rating for UTI stock?

ChartMill assigns a fundamental rating of 5 / 10 to UTI.


What is the valuation status for UTI stock?

ChartMill assigns a valuation rating of 2 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.


Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?

UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.


Can you provide the financial health for UTI stock?

The financial health rating of UNIVERSAL TECHNICAL INSTITUT (UTI) is 5 / 10.


What is the earnings growth outlook for UNIVERSAL TECHNICAL INSTITUT?

The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -31.19% in the next year.